OpRegen Continues to Show Efficacy in Dry AMD Geographic Atrophy

Lineage Cell Therapeutics announced promising data from interim results of the phase 1/2a clinical trial assessing the cell therapy.

Challenging Paradigms in AMD: Gregory S. Hageman, PhD

The executive director of the Steele Center for Translational Medicine at the Moran Eye Center discussed his team’s research in the role of HTRA1.

Gene-Independent Therapeutic Strategies for Retinal Degeneration

Researchers are exploring gene-independent therapeutic strategies to circumvent the challenges of gene-replacement therapies.